Can zinc deficiency impair immune surveillance?

Zinc is required for adaptive and innate immune function, epithelial integrity, and wound repair. The claim is supported overall: the lymphocyte pathway has human deficiency/repletion evidence, while barrier and repair pathways are strongly mechanistic and clinically coherent contributors to local host defense.

Clinical and immune-function evidence

• Zinc deficiency is associated with thymic atrophy, reduced thymulin activity, lymphopenia, altered CD4/CD8 balance, impaired T-cell maturation and proliferation, and lower cytotoxic T-cell/NK-cell activity. These defects can reduce recognition and elimination of infected or abnormal cells.
• In a documented zinc-deficient adult, repletion normalized lymphocyte count, T-cell measures, CD8:CD4 ratio, and NK function. In zinc-deficient nursing-home adults, 30 mg/day for 3 months increased peripheral T-cell numbers and proliferative responses.
• Effects are context-dependent: supplementation did not change leukocyte subsets in healthy men, and a review of 35 randomized trials found only a modest CD4 increase without significant overall changes in total lymphocytes or CD3 cells.

Barrier, repair, and innate mechanisms

• Zinc depletion reduces transepithelial electrical resistance and disrupts F-actin and junctional proteins—occludin, claudins, ZO-1, E-cadherin, and β-catenin—thereby increasing permeability. Zinc-deficient epithelial cells also increase IL-8 and neutrophil-attracting chemokines.
• Deficiency can impair keratinocyte migration/proliferation, re-epithelialization, collagen/extracellular-matrix remodeling, and wound-bed antimicrobial defense. It also reduces neutrophil extracellular-trap formation.
• Persistent epithelial or wound barriers plausibly permit greater microbial entry and inflammatory antigen exposure, weakening local surveillance; this linkage is predominantly mechanistic rather than directly demonstrated in clinical surveillance endpoints.

Clinical implications

• Healing benefits from zinc-containing interventions are heterogeneous but signal possible benefit in pressure injuries (RR 1.44, 95% CI 1.01–2.06; another meta-analysis RR 1.41, 95% CI 1.04–1.92).
• Bottom line: Correcting bona fide zinc deficiency is biologically and clinically justified to support immune-cell function, barrier defense, and repair, but supplementation in zinc-replete individuals should not be assumed to improve immune surveillance.